skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: CMTM5 exhibits tumor suppressor activity through promoter methylation in oral squamous cell carcinoma

Abstract

Highlights: • Down-regulation of CMTM5 expression in OSCC tissues was found. • The promoter methylation status of CMTM5 was measured. • CMTM5-v1 inhibited cell proliferation and migration and induced apoptosis. • CMTM5 might act as a putative tumor suppressor gene in OSCC. - Abstract: Oral squamous cell carcinoma (OSCC) is one of the most common types of malignancies in the head and neck region. CKLF-like MARVEL transmembrane domain-containing member 5 (CMTM5) has been recently implicated as a tumor suppressor gene in several cancer types. Herein, we examined the expression and function of CMTM5 in oral squamous cell carcinoma. CMTM5 was down-regulated in oral squamous cell lines and tumor samples from patients with promoter methylation. Treatment with the demethylating agent 5-aza-2′-deoxycytidine restored CMTM5 expression. In the OSCC cell lines CAL27 and GNM, the ectopic expression of CMTM5-v1 strongly inhibited cell proliferation and migration and induced apoptosis. In addition, CMTM5-v1 inhibited tumor formation in vivo. Therefore, CMTM5 might act as a putative tumor suppressor gene through promoter methylation in oral squamous cell carcinoma.

Authors:
 [1];  [2];  [1]; ;  [3];  [1];  [2];  [3]
  1. Central Laboratory, Peking University School of Stomatology, Beijing (China)
  2. Center for Human Disease Genomics, Department of Immunology, Key Laboratory of Medical Immunology, Ministry of Health, School of Basic Medical Sciences, Peking University, Beijing (China)
  3. Department of Oral Pathology, Peking University School of Stomatology, Beijing (China)
Publication Date:
OSTI Identifier:
22416414
Resource Type:
Journal Article
Journal Name:
Biochemical and Biophysical Research Communications
Additional Journal Information:
Journal Volume: 447; Journal Issue: 2; Other Information: Copyright (c) 2014 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.; Country of input: International Atomic Energy Agency (IAEA); Journal ID: ISSN 0006-291X
Country of Publication:
United States
Language:
English
Subject:
60 APPLIED LIFE SCIENCES; ANIMAL TISSUES; APOPTOSIS; CARCINOMAS; CELL PROLIFERATION; DEOXYCYTIDINE; GENES; IN VIVO; METHYLATION; MIGRATION; NECK; PATIENTS; PROMOTERS

Citation Formats

Zhang, Heyu, Nan, Xu, Li, Xuefen, Chen, Yan, Zhang, Jianyun, Sun, Lisha, Han, Wenlin, and Li, Tiejun. CMTM5 exhibits tumor suppressor activity through promoter methylation in oral squamous cell carcinoma. United States: N. p., 2014. Web. doi:10.1016/J.BBRC.2014.03.158.
Zhang, Heyu, Nan, Xu, Li, Xuefen, Chen, Yan, Zhang, Jianyun, Sun, Lisha, Han, Wenlin, & Li, Tiejun. CMTM5 exhibits tumor suppressor activity through promoter methylation in oral squamous cell carcinoma. United States. https://doi.org/10.1016/J.BBRC.2014.03.158
Zhang, Heyu, Nan, Xu, Li, Xuefen, Chen, Yan, Zhang, Jianyun, Sun, Lisha, Han, Wenlin, and Li, Tiejun. 2014. "CMTM5 exhibits tumor suppressor activity through promoter methylation in oral squamous cell carcinoma". United States. https://doi.org/10.1016/J.BBRC.2014.03.158.
@article{osti_22416414,
title = {CMTM5 exhibits tumor suppressor activity through promoter methylation in oral squamous cell carcinoma},
author = {Zhang, Heyu and Nan, Xu and Li, Xuefen and Chen, Yan and Zhang, Jianyun and Sun, Lisha and Han, Wenlin and Li, Tiejun},
abstractNote = {Highlights: • Down-regulation of CMTM5 expression in OSCC tissues was found. • The promoter methylation status of CMTM5 was measured. • CMTM5-v1 inhibited cell proliferation and migration and induced apoptosis. • CMTM5 might act as a putative tumor suppressor gene in OSCC. - Abstract: Oral squamous cell carcinoma (OSCC) is one of the most common types of malignancies in the head and neck region. CKLF-like MARVEL transmembrane domain-containing member 5 (CMTM5) has been recently implicated as a tumor suppressor gene in several cancer types. Herein, we examined the expression and function of CMTM5 in oral squamous cell carcinoma. CMTM5 was down-regulated in oral squamous cell lines and tumor samples from patients with promoter methylation. Treatment with the demethylating agent 5-aza-2′-deoxycytidine restored CMTM5 expression. In the OSCC cell lines CAL27 and GNM, the ectopic expression of CMTM5-v1 strongly inhibited cell proliferation and migration and induced apoptosis. In addition, CMTM5-v1 inhibited tumor formation in vivo. Therefore, CMTM5 might act as a putative tumor suppressor gene through promoter methylation in oral squamous cell carcinoma.},
doi = {10.1016/J.BBRC.2014.03.158},
url = {https://www.osti.gov/biblio/22416414}, journal = {Biochemical and Biophysical Research Communications},
issn = {0006-291X},
number = 2,
volume = 447,
place = {United States},
year = {Fri May 02 00:00:00 EDT 2014},
month = {Fri May 02 00:00:00 EDT 2014}
}